These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 4278432)

  • 21. Cardiac glycoside sensitivity of (Na + +K + )-activated ATPase in new-born rats.
    Akera T; Hook JB; Tobin T; Brody TM
    Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):699-706. PubMed ID: 4264311
    [No Abstract]   [Full Text] [Related]  

  • 22. Red cell Na+,K+-ATPase: a method for estimating the extent of inhibition of an enzyme sample containing an unknown amount of bound cardiac glycoside.
    Huang W-H ; Askari A
    Life Sci; 1975 Apr; 16(8):1253-61. PubMed ID: 124377
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of potassium, temperature and time on ouabain interaction with the cardiac Na+, K+-ATPase: further evidence supporting an allosteric site.
    Allen JC; Schwartz A
    J Mol Cell Cardiol; 1970 Mar; 1(1):39-45. PubMed ID: 4255499
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on cardioactive steroids. III. Characterization of different cardiac glycosides by their effects on contractility and rhythmicity at different extracellular potassium concentrations.
    Haustein KO; Graumann G; Stephan B
    Acta Biol Med Ger; 1975; 34(6):1065-73. PubMed ID: 1199622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclassification of cardiac glycoside receptors.
    Godfraind T
    Basic Res Cardiol; 1984; 79 Suppl():27-34. PubMed ID: 6331377
    [No Abstract]   [Full Text] [Related]  

  • 26. A possible biochemical explanation for the insensitivity of the rat to cardiac glycosides.
    Allen JC; Schwartz A
    J Pharmacol Exp Ther; 1969 Jul; 168(1):42-6. PubMed ID: 4240031
    [No Abstract]   [Full Text] [Related]  

  • 27. Interactions of cardiac glycosides with cardiac cells. III. Alterations in the sensitivity of (Na+ +K+)-ATPase to inhibition by ouabain in rat hearts.
    Schwalb H; Dickstein Y; Heller M
    Biochim Biophys Acta; 1982 Jul; 689(2):241-8. PubMed ID: 6126212
    [No Abstract]   [Full Text] [Related]  

  • 28. Electrolyte-dependence of cardiac glycoside actions at the cellular and subcellular level.
    Klaus W; Fricke U
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():393-9. PubMed ID: 145631
    [No Abstract]   [Full Text] [Related]  

  • 29. Irreversible inhibition of 3H-ouabain binding to Na+ +K+ -ATPase by digoxigenin-3,12-dibromoacetate, an alkylating derivative of digoxigenin.
    Tobin T; Abramson H
    Eur J Pharmacol; 1975; 32(02):243-50. PubMed ID: 125205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nature of the transport adenosine triphosphatase-digitalis complex. VIII. The relationship between in vivo-formed (3-H-ouabain-Na+, K+-adenosine triphosphatase) complex and ouabain-induced positive inotropism.
    Allen JC; Entman ML; Schwartz A
    J Pharmacol Exp Ther; 1975 Jan; 192(1):105-12. PubMed ID: 123584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of cardiac glycoside inhibition of the (Na+-K+)-dependent ATPase from cardiac tissue.
    Matsui H; Schwartz A
    Biochim Biophys Acta; 1968 Mar; 151(3):655-63. PubMed ID: 4230809
    [No Abstract]   [Full Text] [Related]  

  • 32. On the reversibility of binding of cardiotonic steroids to a partially purified (Na+K)-activated adenosinetriphosphatase from beef brain.
    Yoda A; Hokin LE
    Biochem Biophys Res Commun; 1970 Aug; 40(4):880-6. PubMed ID: 4251204
    [No Abstract]   [Full Text] [Related]  

  • 33. Ouabain-receptor interactions in (Na + +K + )-ATPase preparations from different tissues and species. Determination of kinetic constants and dissociation constants.
    Erdmann E; Schoner W
    Biochim Biophys Acta; 1973 May; 307(2):386-98. PubMed ID: 4268076
    [No Abstract]   [Full Text] [Related]  

  • 34. Ouabain-receptor interactions in (Na+ + K+)-ATPase preparations. 3. On the stability of the ouabain receptor against physical treatment, hydrolases and SH reagents.
    Erdmann E; Schoner W
    Biochim Biophys Acta; 1973 Dec; 330(3):316-24. PubMed ID: 4272501
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiac glycoside receptor, (Na+ + K+)-ATPase activity and force of contraction in rat heart.
    Erdmann E; Philipp G; Scholz H
    Biochem Pharmacol; 1980 Dec; 29(24):3219-29. PubMed ID: 6260108
    [No Abstract]   [Full Text] [Related]  

  • 36. Ouabain binding to (Na+ plus K+)-ATPase. Effects of nucleotide analogues and ethacrynic acid.
    Tobin T; Akera T; Lee CY; Brody TM
    Biochim Biophys Acta; 1974 Apr; 345(1):102-17. PubMed ID: 4275608
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
    Chopra A; Gupta RS
    J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation of cardiac glycoside binding to their receptors and inhibition of (Na + K)-active ATPase. Clinical significance and application possibilities].
    Erdmann E; Schoner W
    Verh Dtsch Ges Inn Med; 1974; 80():1075-7. PubMed ID: 4281574
    [No Abstract]   [Full Text] [Related]  

  • 39. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. II. Association rate constants of various enzyme-cardiac glycoside complexes.
    Yoda A; Yoda S; Sarrif AM
    Mol Pharmacol; 1973 Nov; 9(6):766-73. PubMed ID: 4271632
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on cardioactive steroids. II. Structure-activity relationships in the isolated guinea-pig heart.
    Haustein KO; Hauptmann J
    Pharmacology; 1974; 11(3):129-38. PubMed ID: 4275488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.